Literature DB >> 12093161

USP7, a ubiquitin-specific protease, interacts with ataxin-1, the SCA1 gene product.

Sunghoi Hong1, Sung-Jo Kim, Sojeong Ka, Inho Choi, Seongman Kang.   

Abstract

Spinocerebellar ataxia type 1 (SCA1) is an autosomal-dominant neurodegenerative disorder characterized by ataxia and progressive motor deterioration. SCA1 has been known to associate with elongated polyglutamine tract in ataxin-1, the SCA1 gene product. Using the yeast two-hybrid system, we have found that USP7, a ubiquitin-specific protease, binds to ataxin-1. Further experiments with deletion mutants indicated that the C-terminal region of ataxin-1 was essential for the interaction. Liquid beta-galactosidase assay and coimmunoprecipitation experiments revealed that the strength of the interaction between USP7 and ataxin-1 is influenced by the length of the polyglutamine tract in the ataxin-1; weaker interaction was observed in mutant ataxin-1 with longer polyglutamine tract and USP7 was not recruited to the mutant ataxin-1 aggregates in the Purkinje cells of SCA1 transgenic mice. Our results suggest that altered function of the ubiquitin system can be involved in the pathogenesis of spinocerebellar ataxia type 1. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093161     DOI: 10.1006/mcne.2002.1103

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  14 in total

Review 1.  Balancing act: deubiquitinating enzymes in the nervous system.

Authors:  Sokol V Todi; Henry L Paulson
Journal:  Trends Neurosci       Date:  2011-06-24       Impact factor: 13.837

2.  Roles of HAUSP-mediated p53 regulation in central nervous system development.

Authors:  N Kon; J Zhong; Y Kobayashi; M Li; M Szabolcs; T Ludwig; P D Canoll; W Gu
Journal:  Cell Death Differ       Date:  2011-02-25       Impact factor: 15.828

3.  Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy.

Authors:  Anna Pluciennik; Yuhong Liu; Elana Molotsky; Gregory B Marsh; Bedri Ranxhi; Frederick J Arnold; Sophie St-Cyr; Beverly Davidson; Naemeh Pourshafie; Andrew P Lieberman; Wei Gu; Sokol V Todi; Diane E Merry
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

4.  Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin-1.

Authors:  Akifumi Mizutani; Lei Wang; Harini Rajan; Parminder J S Vig; William A Alaynick; Joshua P Thaler; Chih-Cheng Tsai
Journal:  EMBO J       Date:  2005-08-25       Impact factor: 11.598

Review 5.  The ubiquitin proteasome system in neuropathology.

Authors:  Norman L Lehman
Journal:  Acta Neuropathol       Date:  2009-07-14       Impact factor: 17.088

6.  Inactivation of HAUSP in vivo modulates p53 function.

Authors:  N Kon; Y Kobayashi; M Li; C L Brooks; T Ludwig; W Gu
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

Review 7.  Clinical, genetic, molecular, and pathophysiological insights into spinocerebellar ataxia type 1.

Authors:  Antoni Matilla-Dueñas; Robert Goold; Paola Giunti
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

8.  Deubiquitination of NF-κB by Ubiquitin-Specific Protease-7 promotes transcription.

Authors:  Amy Colleran; Patricia E Collins; Christine O'Carroll; Abrar Ahmed; Xicheng Mao; Bettina McManus; Patrick A Kiely; Ezra Burstein; Ruaidhrí J Carmody
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-24       Impact factor: 11.205

Review 9.  An optimal ubiquitin-proteasome pathway in the nervous system: the role of deubiquitinating enzymes.

Authors:  Gorica Ristic; Wei-Ling Tsou; Sokol V Todi
Journal:  Front Mol Neurosci       Date:  2014-08-19       Impact factor: 5.639

Review 10.  From pathways to targets: understanding the mechanisms behind polyglutamine disease.

Authors:  Jonasz Jeremiasz Weber; Anna Sergeevna Sowa; Tina Binder; Jeannette Hübener
Journal:  Biomed Res Int       Date:  2014-09-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.